Gainers

• Immuron (NASDAQ:IMRN) stock increased by 64.9% to $1.83 during Friday's pre-market session. The company's market cap stands at $8.9 million.
• Akanda (NASDAQ:AKAN) shares increased by 27.52% to $4.68. The company's market cap stands at $1.9 million.
• Niki BioSolutions (NASDAQ:NIKI) stock rose 15.66% to $7.53. The market value of their outstanding shares is at $5.3 million.
• GridAI Technologies (NASDAQ:GRDX) shares moved upwards by 12.79% to $3.35. The market value of their outstanding shares is at $21.1 million.
• Artelo Biosciences (NASDAQ:ARTL) shares rose 11.4% to $6.93. The market value of their outstanding shares is at $3.4 million.
• XORTX Therapeutics (NASDAQ:XRTX) shares increased by 11.16% to $2.39. The company's market cap stands at $3.9 million.

Losers

• BioXcel Therapeutics (NASDAQ:BTAI) stock decreased by 19.1% to $0.1 during Friday's pre-market session. The market value of their outstanding shares is at $3.6 million.
• Dogwood Therapeutics (NASDAQ:DWTX) shares decreased by 9.75% to $2.13. The company's market cap stands at $80.2 million.
• Gelteq (NASDAQ:GELS) stock fell 9.5% to $0.81. The company's market cap stands at $9.5 million.
• Aethlon Medical (NASDAQ:AEMD) stock decreased by 9.33% to $1.75. The company's market cap stands at $1.3 million.
• bioAffinity Technologies (NASDAQ:BIAF) shares fell 9.24% to $11.6. The market value of their outstanding shares is at $7.5 million.
• Cyclerion Therapeutics (NASDAQ:CYCN) shares declined by 6.05% to $4.66. The market value of their outstanding shares is at $23.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.